GENEVA, July 31 -- SYNNOVATION THERAPEUTICS, INC. filed a patent application (US2026/012262) for “BENZIMIDAZOLE DERIVATIVES WHICH AVR AS MODULATORS OF TNF-ALPHA”. With publication no. WO/2026/161638, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61P 19/02
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....